FAIRNESS ALERT: ROSEN, A TOP LAW FIRM, Encourages Lossy Novavax, Inc. Investors to Obtain Legal Counsel Before Important Securities Class Action – NVAX Deadline

0

NEW YORK–(COMMERCIAL THREAD) –WHY: Rosen Law Firm, a global investor rights law firm, reminds buyers of securities of Novavax, Inc. (NASDAQ: NVAX) between March 2, 2021 and October 19, 2021 inclusive (the “Class Period” ), the important January 11, 2022 principal applicant deadline.

SO WHAT: If you purchased Novavax securities during the Class Period, you may be entitled to compensation without payment of any fees or additional charges through a contingency fee agreement.

WHAT TO DO NEXT: To join the Novavax class action, go to http://www.rosenlegal.com/cases-register-2181.html or call Phillip Kim, Esq. toll free at 866-767-3653 or by emailing [email protected] or [email protected] for information on the class action. A class action has already been filed. If you wish to act as the principal applicant, you must apply to the Court no later than January 11, 2022. A principal plaintiff is a representative party acting on behalf of the other members of the class to direct the litigation.

WHY THE ROSEN LAW: We encourage investors to select qualified advisors with a track record of success in leadership roles. Often, companies issuing opinions do not have significant experience, resources or recognition by their peers. Be wise in choosing a lawyer. Rosen law firm represents investors around the world, focusing its practice on class actions in securities and derivative litigation between shareholders. Rosen law firm has secured the largest securities class action settlement against a Chinese company. Rosen law firm was ranked # 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017. The firm has been ranked in the top 4 every year since 2013 and has recovered hundreds millions of dollars for investors. In 2019 alone, the company raised more than $ 438 million for investors. In 2020, founding partner Laurence Rosen was appointed by law360 as the Titan of Plaintiffs’ Bar. Many of the firm’s lawyers have been recognized by Lawdragon and Super Lawyers.

CASE DETAILS: According to the lawsuit, the defendants throughout the Class Period made false and / or misleading statements and / or failed to disclose: (1) Novavax overestimated its manufacturing capabilities and downplayed manufacturing issues that would have an impact. impact on its approval schedule for NVX-CoV2373 (the Company’s product candidate for COVID-19 vaccine); (2) as a result, Novavax was unlikely to meet the regulatory timelines for Emergency Use Authorization (EUA) for NVX-CoV2373; (3) as a result, the Company overestimated the regulatory and commercial outlook for NVX-CoV2373; and (4) Accordingly, the Company’s public statements were materially false and misleading at all relevant times because of the foregoing, the defendants’ public statements were materially false and / or misleading at all relevant times. When the real details entered the market, the lawsuit claims that investors have suffered damage.

To join the Novavax class action, go to http://www.rosenlegal.com/cases-register-2181.html or call Phillip Kim, Esq. toll free at 866-767-3653 or by emailing [email protected] or [email protected] for information on the class action.

No class has been certified. Until a group is certified, you are not represented by a lawyer unless you hire one. You can choose the lawyer of your choice. You can also remain an absent group member and do nothing at this point. The ability of an investor to participate in any potential future payback does not depend on whether he is a principal applicant.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Lawyer advertising. Previous results do not guarantee a similar result.



Source link

Share.

Comments are closed.